Literature DB >> 26055314

Trigeminal root entry zone involvement in neuromyelitis optica and multiple sclerosis.

Atsuhiko Sugiyama1, Masahiro Mori2, Hiroki Masuda2, Tomohiko Uchida2, Mayumi Muto2, Akiyuki Uzawa2, Shoichi Ito3, Satoshi Kuwabara2.   

Abstract

Trigeminal root entry zone abnormality on brain magnetic resonance imaging has been frequently reported in multiple sclerosis patients, but it has not been investigated in neuromyelitis optica patients. Brain magnetic resonance imaging of 128 consecutive multiple sclerosis patients and 46 neuromyelitis optica patients was evaluated. Trigeminal root entry zone abnormality was present in 11 (8.6%) of the multiple sclerosis patients and two (4.3%) of the neuromyelitis optica patients. The pontine trigeminal root entry zone may be involved in both multiple sclerosis and neuromyelitis optica.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Magnetic resonance imaging; Multiple sclerosis; Neuromyelitis optica; Trigeminal nerve; Trigeminal neuralgia; Trigeminal root entry zone

Mesh:

Year:  2015        PMID: 26055314     DOI: 10.1016/j.jns.2015.06.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  4 in total

1.  Bilateral trigeminal root entry zone enhancement in MOG-IgG-associated brainstem encephalitis.

Authors:  Yaoyao Shen; Zhijuan Cheng; Chenguang Zhou
Journal:  Neurol Sci       Date:  2018-12-05       Impact factor: 3.307

Review 2.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

Review 3.  Multiple Sclerosis-Related Pain Syndromes: An Imaging Update.

Authors:  Amir Mazhari
Journal:  Curr Pain Headache Rep       Date:  2016-12

4.  Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon hispidus.

Authors:  Marina S Boukhvalova; Emma Mortensen; Aissatou Mbaye; Diego Lopez; Lorne Kastrukoff; Jorge C G Blanco
Journal:  J Virol       Date:  2019-12-12       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.